Decreased expression of megalin and cubilin and altered mitochondrial activity in tenofovir nephrotoxicity.
暂无分享,去创建一个
S. Moestrup | J. Bastard | F. Lescure | G. Pialoux | S. Fellahi | C. Adam | I. Brochériou | P. Ronco | P. Girard | E. Plaisier | Alexandre Cez | I. Brocheriou
[1] David Thompson,et al. On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection. , 2015, The New England journal of medicine.
[2] J. Hirsch,et al. Nonalbumin proteinuria predominates in biopsy-proven tenofovir nephrotoxicity , 2015, AIDS.
[3] C. Antignac,et al. Dedifferentiation and aberrations of the endolysosomal compartment characterize the early stage of nephropathic cystinosis. , 2014, Human molecular genetics.
[4] F. Lescure,et al. Tubulointerstitial nephropathies in HIV-infected patients over the past 15 years: a clinico-pathological study. , 2013, Clinical journal of the American Society of Nephrology : CJASN.
[5] B. Harding,et al. Receptor-mediated endocytosis and endosomal acidification is impaired in proximal tubule epithelial cells of Dent disease patients , 2013, Proceedings of the National Academy of Sciences.
[6] Peter Reiss,et al. Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study. , 2013, The Journal of infectious diseases.
[7] E. Christensen,et al. Endocytic receptors in the renal proximal tubule. , 2012, Physiology.
[8] M. Shlipak,et al. Association of tenofovir exposure with kidney disease risk in HIV infection , 2012, AIDS.
[9] V. D’Agati,et al. Tenofovir nephrotoxicity: acute tubular necrosis with distinctive clinical, pathological, and mitochondrial abnormalities. , 2010, Kidney international.
[10] M. Tonelli,et al. Systematic review and meta-analysis: renal safety of tenofovir disoproxil fumarate in HIV-infected patients. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[11] A. Mocroft,et al. Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients , 2010, AIDS.
[12] S. de Seigneux,et al. Immunoglobulin deposition disease with a membranous pattern and a circulating monoclonal immunoglobulin G with charge-dependent aggregation properties. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[13] U. Walker,et al. Mitochondrial Tubulopathy in Tenofovir Disoproxil Fumarate-Treated Rats , 2009, Journal of acquired immune deficiency syndromes.
[14] M. Jadoul,et al. Tenofovir-related acute kidney injury and proximal tubule dysfunction precipitated by diclofenac: a case of drug-drug interaction. , 2009, Clinical nephrology.
[15] S. Hosseini,et al. Tenofovir renal toxicity targets mitochondria of renal proximal tubules , 2009, Laboratory Investigation.
[16] Huy Trinh,et al. Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B. , 2008, The New England journal of medicine.
[17] L. P. Van den Heuvel,et al. Urinary protein excretion pattern and renal expression of megalin and cubilin in nephropathic cystinosis. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[18] Yuichi Sugiyama,et al. Functional Involvement of Multidrug Resistance-Associated Protein 4 (MRP4/ABCC4) in the Renal Elimination of the Antiviral Drugs Adefovir and Tenofovir , 2007, Molecular Pharmacology.
[19] K. Robinson,et al. Mechanism of Active Renal Tubular Efflux of Tenofovir , 2006, Antimicrobial Agents and Chemotherapy.
[20] G. Braden,et al. Tenofovir-associated acute and chronic kidney disease: a case of multiple drug interactions. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[21] J. Gallant,et al. Long-term renal safety of tenofovir disoproxil fumarate in antiretroviral-naive HIV-1-infected patients. Data from a double-blind randomized active-controlled multicentre study. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[22] Joel E Gallant,et al. Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial. , 2004, JAMA.
[23] J. Reynes,et al. Renal tubular dysfunction associated with tenofovir therapy: report of 7 cases. , 2004, Journal of acquired immune deficiency syndromes.
[24] P. Courtoy,et al. Loss of chloride channel ClC-5 impairs endocytosis by defective trafficking of megalin and cubilin in kidney proximal tubules , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[25] D. Droz,et al. Tenofovir-related nephrotoxicity in human immunodeficiency virus-infected patients: three cases of renal failure, Fanconi syndrome, and nephrogenic diabetes insipidus. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[26] J. Rossert,et al. Fanconi syndrome and renal failure induced by tenofovir: a first case report. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[27] R. Schooley,et al. Tenofovir DF in antiretroviral-experienced patients: results from a 48-week, randomized, double-blind study , 2002, AIDS.
[28] T. Cihlar,et al. Assessment of Mitochondrial Toxicity in Human Cells Treated with Tenofovir: Comparison with Other Nucleoside Reverse Transcriptase Inhibitors , 2002, Antimicrobial Agents and Chemotherapy.
[29] V. D’Agati,et al. Adefovir nephrotoxicity: possible role of mitochondrial DNA depletion. , 2001, Human pathology.
[30] T. Cihlar,et al. NUCLEOSIDES, NUCLEOTIDES & NUCLEIC ACIDS, 20(4–7), 641–648 (2001) HUMAN RENAL ORGANIC ANION TRANSPORTER 1 (hOAT1) AND ITS ROLE IN THE NEPHROTOXICITY OF ANTIVIRAL NUCLEOTIDE ANALOGS , 2003 .
[31] S. Moestrup,et al. Urinary megalin deficiency implicates abnormal tubular endocytic function in Fanconi syndrome. , 2002, Journal of the American Society of Nephrology : JASN.
[32] E. Bonilla,et al. Optical imaging techniques (histochemical, immunohistochemical, and in situ hybridization staining methods) to visualize mitochondria. , 2001, Methods in cell biology.